The global Pharmaceutical Peptides Services market size is predicted to grow from US$ 5985 million in 2025 to US$ 9437 million in 2031; it is expected to grow at a CAGR of 7.9% from 2025 to 2031.
Pharmaceutical peptides services refer to the range of services offered by pharmaceutical companies or specialized service providers for the development, production, and analysis of peptides for therapeutic purposes. These services typically include:
1. Peptide synthesis: Custom synthesis of peptides based on specific requirements, including the design and production of peptide libraries.
2. Peptide modification: Chemical modification of peptides to enhance their stability, bioavailability, or target specificity.
3. Peptide purification: Purification of synthesized peptides to remove impurities and obtain high-quality products.
4. Peptide characterization: Comprehensive analysis of peptides using techniques such as mass spectrometry, high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) spectroscopy to determine their identity, purity, and structural properties.
5. Peptide formulation: Development of peptide formulations suitable for various administration routes, such as oral, injectable, or topical delivery.
6. Peptide stability studies: Evaluation of the stability of peptides under different conditions, including temperature, pH, and storage conditions, to ensure their shelf-life and efficacy.
7. Peptide bioassays: Testing the biological activity and efficacy of peptides using in vitro and in vivo models to assess their therapeutic potential.
8. Peptide scale-up: Scaling up the production of peptides from laboratory-scale to commercial-scale manufacturing, ensuring consistent quality and quantity.
9. Regulatory support: Assistance in navigating regulatory requirements and guidelines for the development and approval of peptide-based therapeutics.
10. Contract research and manufacturing: Collaborative partnerships or outsourcing of peptide-related research, development, and manufacturing activities to specialized service providers.
These services are essential for the discovery, development, and production of peptide-based drugs, which have gained significant attention in the pharmaceutical industry due to their high specificity, low toxicity, and potential for targeting various diseases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (publisher)' newest research report, the 鈥淧harmaceutical Peptides Services Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Peptides Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Peptides Services sales for 2025 through 2031. With Pharmaceutical Peptides Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Peptides Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Peptides Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Peptides Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Peptides Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Peptides Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Peptides Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Peptides Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Peptide Drug Discovery
Peptide Drug Bioconjugations
Peptide Lead Optimization
Formulation Development
Peptide Drug Screening Service
Total Peptide Library Construction Technology
Other
Segmentation by Application:
Enterprise
Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Peptides
AmbioPharm
3B Pharmaceuticals
ISSAR Pharma
Peptide Institute
WuXi AppTec
JPT Peptide Technologies
CPC Scientific
Red Glead Discovery
Eurofins Scientific
Bio-Synthesis
Bio Basic
CordenPharma
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Peptides Services Market Size (2020-2031)
2.1.2 Pharmaceutical Peptides Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical Peptides Services by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical Peptides Services Segment by Type
2.2.1 Peptide Drug Discovery
2.2.2 Peptide Drug Bioconjugations
2.2.3 Peptide Lead Optimization
2.2.4 Formulation Development
2.2.5 Peptide Drug Screening Service
2.2.6 Total Peptide Library Construction Technology
2.2.7 Other
2.3 Pharmaceutical Peptides Services Market Size by Type
2.3.1 Pharmaceutical Peptides Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical Peptides Services Market Size Market Share by Type (2020-2025)
2.4 Pharmaceutical Peptides Services Segment by Application
2.4.1 Enterprise
2.4.2 Research Institute
2.5 Pharmaceutical Peptides Services Market Size by Application
2.5.1 Pharmaceutical Peptides Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical Peptides Services Market Size Market Share by Application (2020-2025)
3 Pharmaceutical Peptides Services Market Size by Player
3.1 Pharmaceutical Peptides Services Market Size Market Share by Player
3.1.1 Global Pharmaceutical Peptides Services Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical Peptides Services Revenue Market Share by Player (2020-2025)
3.2 Global Pharmaceutical Peptides Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Peptides Services by Region
4.1 Pharmaceutical Peptides Services Market Size by Region (2020-2025)
4.2 Global Pharmaceutical Peptides Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Peptides Services Market Size Growth (2020-2025)
4.4 APAC Pharmaceutical Peptides Services Market Size Growth (2020-2025)
4.5 Europe Pharmaceutical Peptides Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical Peptides Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical Peptides Services Market Size by Country (2020-2025)
5.2 Americas Pharmaceutical Peptides Services Market Size by Type (2020-2025)
5.3 Americas Pharmaceutical Peptides Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Peptides Services Market Size by Region (2020-2025)
6.2 APAC Pharmaceutical Peptides Services Market Size by Type (2020-2025)
6.3 APAC Pharmaceutical Peptides Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Peptides Services Market Size by Country (2020-2025)
7.2 Europe Pharmaceutical Peptides Services Market Size by Type (2020-2025)
7.3 Europe Pharmaceutical Peptides Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Peptides Services by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical Peptides Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Peptides Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Peptides Services Market Forecast
10.1 Global Pharmaceutical Peptides Services Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical Peptides Services Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical Peptides Services Forecast
10.1.3 APAC Pharmaceutical Peptides Services Forecast
10.1.4 Europe Pharmaceutical Peptides Services Forecast
10.1.5 Middle East & Africa Pharmaceutical Peptides Services Forecast
10.2 Americas Pharmaceutical Peptides Services Forecast by Country (2026-2031)
10.2.1 United States Market Pharmaceutical Peptides Services Forecast
10.2.2 Canada Market Pharmaceutical Peptides Services Forecast
10.2.3 Mexico Market Pharmaceutical Peptides Services Forecast
10.2.4 Brazil Market Pharmaceutical Peptides Services Forecast
10.3 APAC Pharmaceutical Peptides Services Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical Peptides Services Market Forecast
10.3.2 Japan Market Pharmaceutical Peptides Services Forecast
10.3.3 Korea Market Pharmaceutical Peptides Services Forecast
10.3.4 Southeast Asia Market Pharmaceutical Peptides Services Forecast
10.3.5 India Market Pharmaceutical Peptides Services Forecast
10.3.6 Australia Market Pharmaceutical Peptides Services Forecast
10.4 Europe Pharmaceutical Peptides Services Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmaceutical Peptides Services Forecast
10.4.2 France Market Pharmaceutical Peptides Services Forecast
10.4.3 UK Market Pharmaceutical Peptides Services Forecast
10.4.4 Italy Market Pharmaceutical Peptides Services Forecast
10.4.5 Russia Market Pharmaceutical Peptides Services Forecast
10.5 Middle East & Africa Pharmaceutical Peptides Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmaceutical Peptides Services Forecast
10.5.2 South Africa Market Pharmaceutical Peptides Services Forecast
10.5.3 Israel Market Pharmaceutical Peptides Services Forecast
10.5.4 Turkey Market Pharmaceutical Peptides Services Forecast
10.6 Global Pharmaceutical Peptides Services Forecast by Type (2026-2031)
10.7 Global Pharmaceutical Peptides Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmaceutical Peptides Services Forecast
11 Key Players Analysis
11.1 Creative Peptides
11.1.1 Creative Peptides Company Information
11.1.2 Creative Peptides Pharmaceutical Peptides Services Product Offered
11.1.3 Creative Peptides Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Creative Peptides Main Business Overview
11.1.5 Creative Peptides Latest Developments
11.2 AmbioPharm
11.2.1 AmbioPharm Company Information
11.2.2 AmbioPharm Pharmaceutical Peptides Services Product Offered
11.2.3 AmbioPharm Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 AmbioPharm Main Business Overview
11.2.5 AmbioPharm Latest Developments
11.3 3B Pharmaceuticals
11.3.1 3B Pharmaceuticals Company Information
11.3.2 3B Pharmaceuticals Pharmaceutical Peptides Services Product Offered
11.3.3 3B Pharmaceuticals Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 3B Pharmaceuticals Main Business Overview
11.3.5 3B Pharmaceuticals Latest Developments
11.4 ISSAR Pharma
11.4.1 ISSAR Pharma Company Information
11.4.2 ISSAR Pharma Pharmaceutical Peptides Services Product Offered
11.4.3 ISSAR Pharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ISSAR Pharma Main Business Overview
11.4.5 ISSAR Pharma Latest Developments
11.5 Peptide Institute
11.5.1 Peptide Institute Company Information
11.5.2 Peptide Institute Pharmaceutical Peptides Services Product Offered
11.5.3 Peptide Institute Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Peptide Institute Main Business Overview
11.5.5 Peptide Institute Latest Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Information
11.6.2 WuXi AppTec Pharmaceutical Peptides Services Product Offered
11.6.3 WuXi AppTec Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 WuXi AppTec Main Business Overview
11.6.5 WuXi AppTec Latest Developments
11.7 JPT Peptide Technologies
11.7.1 JPT Peptide Technologies Company Information
11.7.2 JPT Peptide Technologies Pharmaceutical Peptides Services Product Offered
11.7.3 JPT Peptide Technologies Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 JPT Peptide Technologies Main Business Overview
11.7.5 JPT Peptide Technologies Latest Developments
11.8 CPC Scientific
11.8.1 CPC Scientific Company Information
11.8.2 CPC Scientific Pharmaceutical Peptides Services Product Offered
11.8.3 CPC Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 CPC Scientific Main Business Overview
11.8.5 CPC Scientific Latest Developments
11.9 Red Glead Discovery
11.9.1 Red Glead Discovery Company Information
11.9.2 Red Glead Discovery Pharmaceutical Peptides Services Product Offered
11.9.3 Red Glead Discovery Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Red Glead Discovery Main Business Overview
11.9.5 Red Glead Discovery Latest Developments
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Information
11.10.2 Eurofins Scientific Pharmaceutical Peptides Services Product Offered
11.10.3 Eurofins Scientific Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Eurofins Scientific Main Business Overview
11.10.5 Eurofins Scientific Latest Developments
11.11 Bio-Synthesis
11.11.1 Bio-Synthesis Company Information
11.11.2 Bio-Synthesis Pharmaceutical Peptides Services Product Offered
11.11.3 Bio-Synthesis Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Bio-Synthesis Main Business Overview
11.11.5 Bio-Synthesis Latest Developments
11.12 Bio Basic
11.12.1 Bio Basic Company Information
11.12.2 Bio Basic Pharmaceutical Peptides Services Product Offered
11.12.3 Bio Basic Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bio Basic Main Business Overview
11.12.5 Bio Basic Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Pharmaceutical Peptides Services Product Offered
11.13.3 CordenPharma Pharmaceutical Peptides Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
